title: ["A" for Agency, "B" for Basal cell, "C" for Corticotulle, "D" for Danger].
abstract: Without any proof, a governmental agency has decreed that Corticotulle was not enough efficient to be reimbursed by National Health Security. Dealing with treatment of basal cell carcinoma, another governmental agency has published recommendations which even do not follow basic rules of logic. This paper points out that economical and political methods are not scientific or medical ones.
authors.affiliation: Service de chirurgie plastique, hôpital Saint-Louis, 75475 Paris cedex 10, France. marc@revol.org
authors.forename: M
authors.initials: M
authors.lastname: Revol
authors.forename: J-M
authors.initials: JM
authors.lastname: Servant
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002280:Basal Cell Carcinoma / Q000601:surgery*; D005602:France; D006291:Health Policy; D006801:Humans; D009313:National Health Programs; D012051:Reimbursement Mechanisms; D012878:Skin Neoplasms / Q000601:surgery*; D013518:Surgery, Plastic
chemical_list: D000900:Anti-Bacterial Agents